Table 4.

Total BPD Symptom Composite Estimated Means and Difference (95% Confidence Interval)

Timeframe (Assessment)	Intensive Suicide Assessment	Control Assessment	Difference (95% CI)
All Participants
Entire Study (W&M)	1.17 (1.02,1.33)	1.08 (.92,1.24)	.09 (−.13,.31)
Main Obs. (W)	1.11 (.95,1.27)	.96 (.80,1.13)	.15 (−.09,.38)
Main Obs. (D)	.53 (.44, .67)	.46 (.36,.55)	.08 (−.06,.21)
Main Obs. (ESM)	.51 (.41, .60)	.47 (.37, .57)	.04 (−.11,.18)
Follow-up (M)	1.21 (1.05,1.37)	1.15 (.99,1.31)	.06 (−.16,.29)
Non-BPD
Entire Study (W&M)	.87 (.71, 1.03)	.77 (.61, .94)	.10 (−.13,.33)
Main Obs. (W)	.79 (.62, .96)	.65 (.47, .82)	.14 (−.10,.38)
Main Obs. (D)	.37 (.27, .47)	.29 (.19, .39)	.08 (−.06,.22)
Main Obs. (ESM)	.33 (.23, .43)	.28 (.17, .38)	.05 (−.09,.20)
Follow-up (M)	.93 (.77, 1.09)	.85 (.68, 1.02)	.08 (−.15,.32)
BPD
Entire Study (W&M)	1.86 (1.62,2.11)	1.80 (1.55,2.05)	.06 (−.29,.41)
Main Obs. (W)	1.86 (1.60,2.11)	1.72 (1.45, 1.99)	.14 (−.24,.51)
Main Obs. (D)	.91 (.76, 1.05)	.86 (.71, 1.02)	.05 (−.17,.26)
Main Obs. (ESM)	.90 (.75, 1.06)	.89 (.73, 1.05)	.01 (−.21,.24)
Follow-up (M)	1.87 (1.62,2.12)	1.84 (1.59, 2.10)	.03 (−.33,.39)

Note: Significance tests were one-tailed, CIs are two-tailed. None of the differences reached significance at p < .10 or p < .05. W = Weekly assessments, M = Monthly assessments, D = Daily assessments, ESM = ESM assessments